FindTrial
Sign In

Dexmed As An Adjuvant To Local Anaesthesia

Evaluation Of Analgesic Efficacy Of Dexmedetomidine As an Adjuvant To Local Anaesthesia In Maxillofacial Soft Tissue Injuries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048016
Enrollment
80
Registered
2022-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z736- Limitation of activities due to disability

Interventions

Intervention1: inj Dexmedetomidine: Inj Dexmedetomidine 1ug/kg IV route, as bolus for 20 min followed by an infusion of 0.2ug/kg continously as maintenance dose for 1 hour to experimental group.pati

Sponsors

Sri Rajiv Gandhi College of Dental Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA type I and II Soft tissue laceration in maxillofacial region

Exclusion criteria

Exclusion criteria: Hypertension cases, IHD, anticoagulant use, pregnancy, allergies

Design outcomes

Primary

MeasureTime frame
Duration of surgery, postoperative analgesia duration,total analgesic requirement, pain score, Hemodynamic variables, surgeon satisfaction Frequency of analgesia and patient satisfaction scoreTimepoint: At Baseline—

Secondary

MeasureTime frame
Adverse effectsTimepoint: Single visit—

Countries

India

Contacts

Public ContactDr Hemavathi U
drhemau85@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026